Pamela Esposito - Jul 20, 2021 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role
Chief Business Officer
Signature
/s/ Jean Franchi, attorney-in-fact
Stock symbol
REPL
Transactions as of
Jul 20, 2021
Transactions value $
-$559,001
Form type
4
Date filed
7/22/2021, 09:01 PM
Previous filing
Jul 19, 2021
Next filing
Aug 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REPL Common Stock Options Exercise $4.91K +4.86K +2.31% $1.01* 215K Jul 20, 2021 Direct
transaction REPL Common Stock Sale -$161K -4.86K -2.26% $33.05 210K Jul 20, 2021 Direct F1
transaction REPL Common Stock Options Exercise $12.7K +12.5K +5.97% $1.01* 223K Jul 21, 2021 Direct
transaction REPL Common Stock Sale -$416K -12.5K -5.63% $33.17 210K Jul 21, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REPL Employee Stock Option (right to buy) Options Exercise $0 -4.86K -7.09% $0.00 63.7K Jul 20, 2021 Common Stock 4.86K $1.01 Direct F3
transaction REPL Employee Stock Option (right to buy) Options Exercise $0 -12.5K -19.67% $0.00 51.2K Jul 21, 2021 Common Stock 12.5K $1.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
F2 Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 488,102 shares of the Issuer's common stock, 324,649 of which are exercisable as of the date hereof. Due to scrivener's error, footnote 2 of the Form 4 filed on behalf of the reporting person on July 19, 2021 inadvertently overstated the number of options held by the Reporting Person following the transaction reported therein. The amounts stated in this footnote 2 set forth the correct number of options held by the Reporting Person following the transaction reported herein.
F3 The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.